HEREDITARY RED BLOOD CELL DISORDER (DISORDER)

Clinical trials for HEREDITARY RED BLOOD CELL DISORDER (DISORDER) explained in plain language.

Never miss a new study

Get alerted when new HEREDITARY RED BLOOD CELL DISORDER (DISORDER) trials appear

Sign up with your email to follow new studies for HEREDITARY RED BLOOD CELL DISORDER (DISORDER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for rare anemia patients: drug may cut transfusions by a third

Disease control Not yet recruiting

This study tests a drug called luspatercept in 45 people with rare inherited anemias that cause low red blood cells. The goal is to see if it can reduce the need for blood transfusions by at least one third in those who rely on transfusions, or raise hemoglobin levels in those wh…

Matched conditions: HEREDITARY RED BLOOD CELL DISORDER (DISORDER)

Phase: PHASE2 • Sponsor: EuroBloodNet Association • Aim: Disease control

Last updated Apr 30, 2026 15:49 UTC

HEREDITARY RED BLOOD CELL DISORDER (DISORDER)

Get alerted when new HEREDITARY RED BLOOD CELL DISORDER (DISORDER) trials appear

New hope for rare anemia patients: drug may cut transfusions by a third